1.5 Abstract in rivista
 Distribuzione geografica
Continente #
AS - Asia 19.463
NA - Nord America 9.551
EU - Europa 4.039
SA - Sud America 1.335
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 94
Totale 34.783
Nazione #
SG - Singapore 14.000
US - Stati Uniti d'America 9.150
CN - Cina 2.294
IT - Italia 2.001
HK - Hong Kong 1.309
BR - Brasile 962
GB - Regno Unito 624
VN - Vietnam 553
FR - Francia 494
BD - Bangladesh 330
IN - India 306
DE - Germania 266
CA - Canada 210
AR - Argentina 144
NL - Olanda 112
ID - Indonesia 107
TR - Turchia 98
MX - Messico 92
EC - Ecuador 68
AU - Australia 66
CO - Colombia 58
CZ - Repubblica Ceca 57
FI - Finlandia 57
EE - Estonia 54
PK - Pakistan 52
JP - Giappone 51
UA - Ucraina 51
PL - Polonia 45
SA - Arabia Saudita 45
ES - Italia 43
ZA - Sudafrica 43
PH - Filippine 40
IQ - Iraq 39
MY - Malesia 39
EG - Egitto 32
CL - Cile 30
RU - Federazione Russa 29
JM - Giamaica 27
PY - Paraguay 25
VE - Venezuela 25
MD - Moldavia 23
NZ - Nuova Zelanda 22
AE - Emirati Arabi Uniti 21
SE - Svezia 20
TW - Taiwan 20
AT - Austria 19
IE - Irlanda 19
NP - Nepal 17
ET - Etiopia 16
MA - Marocco 16
TN - Tunisia 16
DO - Repubblica Dominicana 14
TH - Thailandia 14
CH - Svizzera 13
AZ - Azerbaigian 12
UZ - Uzbekistan 12
HN - Honduras 11
IR - Iran 11
KZ - Kazakistan 11
LT - Lituania 11
UY - Uruguay 11
KE - Kenya 10
KW - Kuwait 10
DK - Danimarca 9
KR - Corea 9
OM - Oman 9
PT - Portogallo 9
BE - Belgio 8
CR - Costa Rica 8
GH - Ghana 8
HU - Ungheria 8
NO - Norvegia 8
RO - Romania 8
AL - Albania 7
DZ - Algeria 7
GT - Guatemala 7
IL - Israele 7
NG - Nigeria 7
PE - Perù 7
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
GR - Grecia 5
JO - Giordania 5
KG - Kirghizistan 5
LB - Libano 5
LY - Libia 5
NI - Nicaragua 5
PR - Porto Rico 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
BH - Bahrain 4
KH - Cambogia 4
LK - Sri Lanka 4
MK - Macedonia 4
PS - Palestinian Territory 4
AO - Angola 3
BB - Barbados 3
CI - Costa d'Avorio 3
Totale 34.598
Città #
San Jose 2.796
Singapore 1.771
Ashburn 1.592
Rome 1.411
Hong Kong 1.285
Hefei 986
Council Bluffs 690
Dallas 689
Boardman 583
Columbus 500
London 464
Beijing 452
Lauterbourg 432
Shanghai 342
Ho Chi Minh City 209
Los Angeles 190
New York 158
Santa Clara 133
Hanoi 132
San Francisco 124
Pune 114
São Paulo 95
West Jordan 90
Phoenix 84
Milan 78
Munich 70
Amsterdam 69
Toronto 62
Washington 62
Seattle 50
Chicago 48
Brooklyn 45
Mexico City 42
Brno 41
Warsaw 37
Buffalo 36
Sona 36
Montreal 35
Naples 35
Turku 35
Las Vegas 34
Tokyo 33
Frankfurt am Main 30
Rio de Janeiro 29
Quito 27
Chennai 25
Haiphong 24
Riyadh 23
Helsinki 22
Kuala Lumpur 22
Melbourne 22
Jakarta 21
Atlanta 20
Brasília 20
Da Nang 20
Guayaquil 19
Manchester 19
Orem 19
Canberra 18
Hanover 18
Nuremberg 18
Buenos Aires 17
Florence 17
Istanbul 17
New Delhi 17
Paris 17
Baghdad 16
Boston 16
Charlotte 16
Jeddah 16
Johannesburg 16
Philadelphia 15
Porto Alegre 15
Stockholm 15
Sydney 15
Thái Bình 15
Bologna 14
Cairo 14
Curitiba 14
Dhaka 14
Hải Dương 14
Kingston 14
Central 13
Turin 13
Ankara 12
Biên Hòa 12
Bogotá 12
Dublin 12
Manila 12
Addis Ababa 11
Bangkok 11
Belo Horizonte 11
Campinas 11
Glasgow 11
Jacksonville 11
Ninh Bình 11
Secaucus 11
Vienna 11
Baku 10
Brescia 10
Totale 17.115
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 441
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 340
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 335
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 315
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 314
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 306
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 259
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 257
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 251
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 245
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 243
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 240
Effect of hypothermia on human colonic smooth muscle contractility 239
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 238
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 234
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 232
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 231
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 228
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 224
Disclosing 3D Shape of Ossa Genitalia in Primates 222
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 222
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 220
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 220
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 219
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 216
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 215
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 215
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 214
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 213
Does HE4 have a role in the recurrence of ovarian cancer? 213
Diagnosis of labour: the II prospective clinical study 211
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 210
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 209
Assessment of liver function by the exhaled breath-print during chronic liver disease 209
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 207
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 207
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 204
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 197
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 195
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 195
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 194
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 191
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 189
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 184
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 175
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 169
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 153
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 152
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 152
Abruptio placenta and TLRs 2-3-4 148
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 148
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 146
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 144
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 143
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 143
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 141
Alimentazione e gravidanza fisiologica 141
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 137
GH-resistance in different stages of chronic liver disease 137
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 134
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 133
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 132
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 130
Biological effects of cabozantinib on bone microenvironment 129
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 128
A meta-synthesis of experiences of caregivers of people with COPD. 128
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 128
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 127
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 127
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 126
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 125
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 125
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 125
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 124
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 124
Fetal head-symphysis distance: a simple and reliable ultrasound parameter for the intrapartum assessment of the fetal head descent 123
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 123
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 122
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 122
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 121
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 121
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 120
Baccalaureate nursing students’ attitudes towards old people 119
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 119
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 119
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 119
How long is the latent phase of labour? 118
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 117
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 116
Integrated treatment of pancreatic head carcinoma 116
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 115
ALT levels are associated with metabolic parameters and age in a large real-life population. 115
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 114
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 114
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 112
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 110
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 109
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 107
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 106
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 106
Totale 17.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 11 6 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.848 82 163 75 113 203 818 33 84 22 135 35 85
2024/202515.416 230 198 621 65 107 342 218 69 1.260 1.172 5.231 5.903
2025/202614.752 1.366 507 1.119 1.671 536 1.026 4.469 725 998 1.110 676 549
2026/20271.672 162 1.370 140 0 0 0 0 0 0 0 0 0
Totale 34.783